A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma.

  title={A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma.},
  author={Stephen L. Chan and Frankie Mo and Cesar Wong and Charles Ming Lok Chan and Linda K. S. Leung and Edwin Pun Hui and B B Ma and Anthony Tak-cheung Chan and Tony Shu Kam Mok and Winnie Yeo},
  volume={118 16},
BACKGROUND The level of circulating interleukin 10 (IL-10) is elevated in a proportion of patients with hepatocellular carcinoma (HCC). The objective of the current study was to evaluate the prognostic significance of serum the IL-10 level in patients with unresectable HCC. METHODS Patients with unresectable HCC who provided serum at the time of diagnosis were enrolled prospectively in the study. The level of circulating IL-10 in serum samples was determined by enzyme-linked immunosorbent… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 19 extracted citations


Publications referenced by this paper.
Showing 1-10 of 30 references

Management of hepatocellular carcinoma

Journal of Cancer Research and Clinical Oncology • 2014
View 13 Excerpts
Highly Influenced

Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2010
View 1 Excerpt

Estimates of worldwide burden of cancer

J Ferlay, HR Shin, +3 authors DM. Parkin

Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology • 2007

Similar Papers

Loading similar papers…